Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
about
Lung transplantation: overall approach regarding its major aspectsLung transplantationUpdate in lung transplantation 2013.Serial monitoring of exhaled nitric oxide in lung transplant recipientsLongitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation.Symptomatic Respiratory Virus Infection and Chronic Lung Allograft DysfunctionImpact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study.Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.Characteristic patterns in the fibrotic lung. Comparing idiopathic pulmonary fibrosis with chronic lung allograft dysfunction.The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation.The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation.Effect of Lung Transplantation on Health-Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study.Chronic lung allograft dysfunction phenotypes and treatment.Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.Spirometry States the Obvious: Recognizing Bronchiolitis Obliterans Syndrome Early after Hematopoietic Cell Transplantation.Parametric Response Mapping as an Imaging Biomarker in Lung Transplant Recipients.
P2860
Q26770911-673D63C5-D181-46C1-957B-524763321C64Q28085486-EEA83844-80E7-476C-ACF6-D6733AF9924AQ34480293-50862413-C9A7-4039-9382-12A54B7CF19DQ35469930-A51931E8-01FE-4CD9-A650-6A5C804B19E8Q35941658-DEFCC6A8-A16E-4998-80C7-B8B33C0F0F66Q36446117-88D1DB00-DE74-49CB-9BB9-0907E85A44ABQ37090251-80CF362C-3C84-4C02-A0E6-F7A798E429A3Q37247946-ADB84A8F-3650-4987-BEE1-BA31F19D4ACAQ38399493-B6BCFCCC-F47F-4D6F-861A-96D41DD3E291Q38715429-CEB82537-BAE1-4AD5-9679-F1C598CDE071Q40114115-973206A7-84E4-4EAD-AA76-17BB8EFFA304Q40144171-27A28355-FA1E-4918-92A0-E529236B1674Q40541099-37BDDFEE-7787-473E-8BFA-55FE07DF1E51Q41303108-88F19EB0-5755-498E-AEC1-768E500AAA6BQ42721543-F1D536AE-9A1A-4728-A917-343B0ED2B445Q42768766-DF471778-B664-4339-A233-617C2F88CC24Q42768778-779F9FD7-C7BF-4ACC-944A-2C8D4285BEBFQ51751594-26E4F01A-2566-4DA8-87B4-0D04FE30D445
P2860
Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of forced vital capacit ...... ic lung allograft dysfunction.
@en
Impact of forced vital capacit ...... ic lung allograft dysfunction.
@nl
type
label
Impact of forced vital capacit ...... ic lung allograft dysfunction.
@en
Impact of forced vital capacit ...... ic lung allograft dysfunction.
@nl
prefLabel
Impact of forced vital capacit ...... ic lung allograft dysfunction.
@en
Impact of forced vital capacit ...... ic lung allograft dysfunction.
@nl
P2093
P2860
P1476
Impact of forced vital capacit ...... ic lung allograft dysfunction.
@en
P2093
C Ashley Finlen Copeland
Elizabeth N Pavlisko
Jamie L Todd
John M Reynolds
Rahil Jain
Scott M Palmer
P2860
P304
P356
10.1164/RCCM.201306-1155OC
P407
P577
2014-01-01T00:00:00Z